Abstract
The research group has been studying salivary gland tumours (SGT) for 15 years, focusing on the transition from pleomorphic adenoma (PA) to carcinoma ex-PA (CXAP). Although previous research has contributed to the understanding of these tumours, it has also highlighted the promising prospect of using metabolic reprogramming (MR) as a therapeutic target. In this project, we aim to evaluate…